NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

exwannabe,

I thought you were made keenly aware by sentiment stocks that the pseudo progressors were obviously dealt with by quiet regulator intervention after they saw what Dr. Prins and Dr. Liau were talking about with regard to the mesenchymal subset and mesenchymal phenotype transitioning that might have something to do with the whole Phase 3 trial group of patients living longer. Could they be waiting on entire group statistical significance what with so many late entries, delayed PFS in the treatment arm and all. That would kind of keep everything about those trials on the down low right? Remember, it was big pharma research that proved DC vaccines improved patient outcomes for those given their checkpoint inhibitors. FDA can't disregard this third party evidence because it's already in the books.